Citadel Advisors
SGFY

Citadel Advisors’s Signify Health, Inc. SGFY Stock Holding History

Citadel Advisors’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-124,376
Closed -$3.56M – 16023
2022
Q4 		$3.56M Sell
124,376
-615,654
-83% -$17.8M ﹤0.01% 4464
2022
Q3 		$21.6M Sell
740,030
-2,743,094
-79% -$63.2M ﹤0.01% 1794
2022
Q2 		$48.1M Buy
3,483,124
+352,626
+11% +$4.96M 0.01% 1045
2022
Q1 		$56.8M Buy
3,130,498
+2,154,170
+221% +$30.9M 0.01% 1020
2021
Q4 		$13.9M Buy
976,328
+566,290
+138% +$8.76M ﹤0.01% 2531
2021
Q3 		$7.33M Buy
410,038
+210,331
+105% +$5.41M ﹤0.01% 3608
2021
Q2 		$6.08M Buy
199,707
+177,014
+780% +$4.87M ﹤0.01% 4028
2021
Q1 		$664K Buy
+22,693
New +$702K ﹤0.01% 9061

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Citadel Advisors's SGFY Position: Q1 2023 in Review

Citadel Advisors sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 124,376 shares — an estimated $3.56M sold.

Citadel Advisors first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $56.8M in Q1 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Citadel Advisors reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 124,376 Signify Health, Inc. shares in Q1 2023, an estimated $3.56M.
  • Citadel Advisors first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Citadel Advisors's Signify Health, Inc. position peaked at $56.8M in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.